Cytochrome b5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy

✍ Scribed by Věra Kotrbová; Barbora Mrázová; Michaela Moserová; Václav Martínek; Petr Hodek; Jiří Hudeček; Eva Frei; Marie Stiborová

• Book ID: 113489525
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 784 KB
• Volume: 82
• Category: Article
• ISSN: 0006-2952
• DOI: 10.1016/j.bcp.2011.06.003